Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06340620 · ClinicalTrials.gov registry record · NA
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
A NA study of Pancreatic Cancer and Gastrointestinal Cancer, sponsored by Orlando Health.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT06340620: Recruiting NA study of Pancreatic Cancer and Gastrointestinal Cancer, sponsored by Orlando Health.
NCT06340620 is a NA study of Pancreatic Cancer and Gastrointestinal Cancer that is actively recruiting participants, run by Orlando Health. The registered enrollment target is 140 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06340620, a NA study of Pancreatic Cancer and Gastrointestinal Cancer, is actively recruiting participants, sponsored by Orlando Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.
Primary Outcome
Rate of successful completion of the requisite examination during EUS between the EndoSound Vision System and standard echoendoscopes will be assessed, compared as a percentage of successfully completed examinations between the standard echoendoscope and Endosound Vision System.
Conditions Studied
Interventions
- DEVICE Endoscopic ultrasound examination
Study Locations (1)
Florida
- Orlando Health - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06340620 shows while recruiting
NCT06340620 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (64% lower).
The record links to 9 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic ultrasound examination is the first listed.
NCT06340620 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06340620 about?
NCT06340620 is a clinical study titled "EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope". This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.
What is the current status of trial NCT06340620?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2024-03-25. Estimated completion is 2027-12.
What conditions does trial NCT06340620 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Gastrointestinal Cancer, Pancreatic Cyst, Bile Duct Cancer, Pancreatic Disease.
What interventions are being tested in trial NCT06340620?
The interventions under investigation include: Endoscopic ultrasound examination (DEVICE).
Who is sponsoring clinical trial NCT06340620?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06340620 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06340620's enrollment target sits among peer trials
140 82nd of 278 higher than 196 of 278 other Pancreatic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
RECRUITING · NA
-
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
RECRUITING · NA
-
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI